Stop looking for answers,
innovate with the right partner

Seeking Digestive Wellness Solutions

• Posted by The Procter & Gamble Company
• ·
• Project Size : 250,000 - 1,000,000 €

We are interested in products, technologies and packaging that will improve the benefit areas of: Managing and/or enhancing Digestive Wellness; Improving the consumer usage experience and delighting our consumers; and/or Complimenting our portfolio (Metamucil, Pepto Bismol, Align).

Seeking injectable, highly flexible sealing system for personal care devices

• Posted by The Procter & Gamble Company
• ·
• Project Size : 250,000 - 1,000,000 €

We are looking for a material /process that allows to inject a flexible sealing / fluid barrier in particular areas of an already assembled device and that can fill gaps in the range of 1 mm – 3 mm between movable and fixed parts.

Seeking Solutions for Enhanced Delivery of Oral Care Actives and Flavors

• Posted by The Procter & Gamble Company
• ·
• Project Size : 250,000 - 1,000,000 €

To improve the performance and consumer experience of oral care products using formulation excipients to improve deposition, retention and protection of actives, flavors, and sensates for extended periods

RAR-related Orphan Receptor-γ Targeted Library

• Posted by Taras Maiula from Otava Research Institute
• ·
• Innovative Products and Technologies

The Retinoic Acid Receptor-related Orphan Receptor-γ (RORγ, RORc, NR1F3, RORG, RZR-GAMMA, RZRG, TOR or IMD42) plays an important role in metabolism, inimmunity and circadian rhythm. Abnormal functioning of RORγ is associated with inflammatory, immune and skin diseases including psoriasis. Antagonists and inverse agonists of this receptor may have therapeutic potential in the treatment of such diseases. https://bit.ly/461Jypm

Veggletto Vegetarian Egg Replacement Technology

• Posted by Byron Food Science Pty Limited
• ·
• Patents for licensing

The Veggletto® Technology is a break-through system for egg-alternative cooking that is good for you AND “tastes just like the real thing”! Why Veggletto®? The egg industry is fraught with problems in product safety, instability, animal welfare issues, high costs, major waste streams and is unsustainable. More than 30% of the world’s population is vegan or vegetarian. The Veggletto® Technology by TVC provides consumers, food service and industry with natural, economical, great tasting egg-like preparations having the culinary and nutritional properties expected of natural eggs. Examples are a convenient omelette dry mix, chilled liquid and retort or frozen ready-meals. Veggletto® is egg-free and vegetarian while Veganetto™ is the vegan equivalent which is in development. Veggletto products are cholesterol-free; gluten-free and lower in fat than natural eggs (the contained fat is healthier). Veggletto® has excellent complete protein value and essential amino acid profile.

Liquid biopsy for early detection of cancer or precision medicine

• Posted by CNIC (TTO) from Spanish National Center for Cardiovascular Research (CNIC)
• ·
• Patents for licensing

Scientists at EMBL-EBI, CNIC and CSIC have discovered a new type of telomere fusion that is not present in blood from healthy donors but can be detected well in the blood of cancer patients. They developed computational tools for the reliable identification of these fusions. Additionally, predictive models have been established that allow for the detection of the presence of a tumour using sequencing data from a blood sample. We hereby present an approach for a highly specific, minimally invasive and early detection of cancer. The sensitivity and false positive rate are comparable to recent liquid biopsy analysis methods. The performance of the tools is comparable across cancer stages. The tool has been validated using close to 10,000 whole genome sequencing datasets.